inforMED
MalfunctionCKA

ALANINE AMINOTRANSFERASE ACC. TO IFCC WITH PYRIDOXAL PHOSPHATE ACTIVATION

Received Mar 13, 2026 · Event occurred Feb 18, 2026

Report 1823260-2026-00913 · MDR key 24598498

Device

Generic name

Nadh Oxidation/nad Reduction, Alt/sgpt

Manufacturer

Roche Diagnostics

Catalog number

05531462190

Lot number

912346

Product problems

  • Low Test Results

Patient

NA · Unknown

  • No Clinical Signs, Symptoms or Conditions

Narrative

Additional Manufacturer Narrative

THE FIELD SERVICE REPRESENTATIVE NOTED THAT DIFFERENT MODULES IN THE LABORATORY HAD SIMILAR ISSUES, AND THAT SAMPLES WITH VALUES BELOW 12 U/L OFTEN REPEATED WITH RESULTS OF <5 U/L WITH NEGATIVE VALUES. AS THE ISSUE AFFECTS DIFFERENT MODULES, THE EVENT IS CONSISTENT WITH A PREANALYTICAL HANDLING ISSUE. THE INVESTIGATION DID NOT IDENTIFY A PRODUCT PROBLEM. BASED ON THE INFORMATION PROVIDED, THE SPECIFIC CAUSE OF THE EVENT COULD NOT BE DETERMINED.

Additional Manufacturer Narrative

E1 INITIAL REPORTER ESTABLISHMENT NAME: (B)(6). THE ANALYZER'S SERIAL NUMBER IS (B)(6). THE INVESTIGATION IS ONGOING.

Description of Event or Problem

THERE WAS AN ALLEGATION OF QUESTIONABLE ALANINE AMINOTRANSFERASE ACC. TO IFCC WITH PYRIDOXAL PHOSPHATE ACTIVATION RESULTS FOR 1 PATIENT SAMPLE ON A COBAS 8000 COBAS C 701 MODULE. THE INITIAL RESULT WAS <5 U/L, AND THE REPEATED RESULT WAS 33 U/L.